No Data
Medifast Is Maintained at Underperform by DA Davidson
Medifast Is Maintained at Underperform by DA
Medifast Price Target Maintained With a $17.50/Share by DA Davidson
Medifast Price Target Maintained With a $17.50/Share by DA
Express News | DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
D.A. Davidson Maintains Medifast(MED.US) With Sell Rating, Maintains Target Price $17.5
D.A. Davidson analyst Linda Bolton Weiser maintains $Medifast(MED.US)$ with a sell rating, and maintains the target price at $17.5.According to TipRanks data, the analyst has a success rate of 44.8%
D.A. Davidson Sticks to Its Sell Rating for Medifast (MED)